• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

After Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 20, 2024 at 11:42: AM
via After picking up the European rights to Eli Lilly’s Emgality and Rayvow late last year, women’s health outfit Organon is upping its migraine accord with the Big Pharma company.

article source
 




Top Bottom
Back
Quote